#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperoxaluria Renal transplant Behcet's syndrome Liposarcoma Retinitis pigmentosa Pleomorphic leiomyosarcoma Thymic carcinoma Neurodegenerative disorder Infantile apnoea Cutaneous T-cell lymphoma refractory Usher's syndrome Mycobacterium abscessus infection Myeloid leukaemia Plasma cell myeloma Prostate cancer More trials…

    Learn about Rare Diseases

    Systemic mastocytosis – Diagnostics Amyotrophic lateral sclerosis – Life with Disease Epidermolysis bullosa Alveolar rhabdomyosarcoma – Life with Disease Uterine leiomyosarcoma – Treatment Small intestine leiomyosarcoma Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Myxofibrosarcoma Osteosarcoma recurrent – Diagnostics Medulloblastoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acetylcholine Chloride Venlafaxine Hydrochloride Neob Vonicog Alfa Sodium Thiosulfate Alteplase Asfotase Alfa Progesterone Ph. Eur. ULEFNERSEN Oditrasertib Glatiramer Acetate Xp-Dc+Tl+Klh MAGNESIUM ACETATE TETRAHYDRATE GRNA-001 Exidavnemab Varenicline Ficlatuzumab VISUGROMAB AZD4360 Apalutamide More therapies…

    Learn about Your Condition

    Ebola disease Anal incontinence Malformation venous Bone marrow failure Gender dysphoria Hand dermatitis Hypersensitivity Diabetic autonomic neuropathy Glomerulonephritis acute Juvenile absence epilepsy Procedural haemorrhage Osteomyelitis acute Strongyloidiasis Tuberculosis Diabetic retinal oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study of orismilast alone or combined with semaglutide for weight management in people with obesity

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Orismilast
    • Semaglutide
    Denmark

  • Study on Thiopental Sodium Dose During Electroconvulsive Therapy for Patients with Major Depressive Disorder

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Thiopental Sodium
    Sweden

  • Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Panitumumab
    • Fluorouracil
    • Folinic Acid
    France Germany Italy Spain

  • Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Cabozantinib
    Italy

  • Study on Reducing Post-Surgery Complications in Cancer Patients Using Ketorolac, Aspirin, and a Drug Combination

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • KETOROLAC TROMETAMOL
    • Acetylsalicylic Acid
    • Sodium Chloride
    Italy

  • Study on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage I
    Investigated Drugs:
    • Vinorelbine
    • Rilvegostomig
    • Carboplatin
    Belgium France Germany Hungary Italy The Netherlands +3
Previous Page
1 … 800 801 802 803 804 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!